MedTrace Logo

Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile

NCT03940066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 169

Last updated 2025-04-06

No results posted yet for this study

Summary

The objective of the study is to evaluate the efficacy of monitoring after discharge of patients with high-risk acute coronary syndrome.

Conditions

Interventions

DEVICE

Biomonitor-2 and Kardia mobile

Implantable cardiac monitor and Smart-phone based electrocardiogram recording

OTHER

No Intervention

No intervention

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Principal Investigators

  • Felipe Rodríguez Entem, MD, PhD · Hospital Universitario Marqués de Valdecilla

  • José M De la Torre Hernández, MD, PhD · Hospital Universitario Marqués de Valdecilla

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-12
Primary Completion
2024-04-08
Completion
2024-06-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03940066 on ClinicalTrials.gov